Rankings
▼
Calendar
LIVN Q4 2020 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena
LIVN
LivaNova PLC
$3B
Q4 2020 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$270M
-6.3% YoY
Gross Profit
$151M
56.1% margin
Operating Income
-$252M
-93.4% margin
Net Income
-$284M
-105.2% margin
EPS (Diluted)
$-5.76
QoQ Revenue Growth
+12.3%
Cash Flow
Operating Cash Flow
$37M
Free Cash Flow
$30M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$2.4B
Total Liabilities
$1.3B
Stockholders' Equity
$1.1B
Cash & Equivalents
$253M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$270M
$288M
-6.3%
Gross Profit
$151M
$205M
-26.1%
Operating Income
-$252M
-$144M
-74.9%
Net Income
-$284M
-$143M
-98.0%
Revenue Segments
Cardiovascular Segment
$160M
59%
Neuromodulation Segment
$109M
41%
Geographic Segments
UNITED STATES
$138M
51%
Locations Excluding The United States And Europe
$77M
28%
Europe
$55M
20%
← FY 2020
All Quarters
Q1 2021 →